Treatment of social phobia with clonazepam and placebo

Clonazepam and placebo were administered in a double-blind pilot study to 75 outpatients with social phobia. The mean maximum dose of clonazepam was 2.4 mg/day at endpoint (range, 0.5 to 3 mg). Treatment was continued for up to 10 weeks. The results of an intent-to-treat analysis indicated superior...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical psychopharmacology 1993-12, Vol.13 (6), p.423-428
Hauptverfasser:	DAVIDSON, J. R. T, POTTS, N, RICHICHI, E, KRISHNAN, R, FORD, S. M, SMITH, R, WILSON, W. H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anxiety - drug therapy Biological and medical sciences Clonazepam - administration & dosage Clonazepam - adverse effects Clonazepam - therapeutic use Double-Blind Method Female Humans Male Medical sciences Neuropharmacology Pharmacology. Drug treatments Phobic Disorders - drug therapy Phobic Disorders - psychology Pilot Projects Psychiatric Status Rating Scales Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!